NPR’s article, “A new chapter for online sales of obesity drug alternatives tests legal limits” focuses on Georgia-based compounder OrderlyMeds and looks at how compounding pharmacies are offering GLP-1s in the post-shortage world. It quotes our own Scott Brunner to bring the story home and remind readers that there’s a lot of nuance in play.